Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Atomoxetine Effect on Attention, Executive Function, and Quality of Life in Veterans With Posttraumatic Stress Disorder

NCT06573970 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT06573970
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06573970 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Atomoxetine Effect on Attention, Executive Function, and Quality of Life in Veterans With Posttraumatic Stress Disorder
Lead sponsor
VA Office of Research and Development
Phase
Phase 4
Overall status
Recruiting
Start date
April 1, 2026
Completion date
September 28, 2029
Enrollment
160 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

posttraumatic stress disorder with attention defic